Agilent Technologies, Inc. which can be found using ticker (A) now have 17 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $165.00 and $130.00 and has a mean share price target at $150.18. (at the time of writing). Given that the stocks previous close was at $154.23 this is indicating there is a potential downside of -2.6%. There is a 50 day moving average of $143.71 while the 200 day moving average is $128.56. The market cap for the company is 45.32B. The stock price for the company is currently is currently $154.64 USD
The potential market cap would be $44,127,997,322 based on the market consensus.
The company has a dividend yield of 2.35%. Other points of data to note are a P/E ratio of 37, revenue per share of $22.97 and a 7.85% return on assets.
Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.
